Visceral angiosarcoma: A nationwide analysis of treatment factors and outcomes.
Leah E HendrickBenjamin R ZambettiDenise L WongPaxton V DicksonEvan S GlazerDavid ShibataMartin D FlemingMiriam W TsaoDavid C PortnoyJeremiah L DenevePublished in: Journal of surgical oncology (2022)
Visceral angiosarcomas are rare tumors with poor outcomes. Liver/biliary origin, higher tumor grade, and larger tumor size demonstrate worse outcomes. While R0 resection remains the mainstay of treatment, patients with R1/R2 resection have improved survival with addition of chemotherapy. Consideration should be made for multimodal therapy in these patients.